Chemed (CHE)
(Real Time Quote from BATS)
$566.54 USD
+6.12 (1.09%)
Updated Apr 29, 2024 03:50 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CHE 566.54 +6.12(1.09%)
Will CHE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed (CHE) Q1 Earnings Miss Estimates
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Chemed (CHE) Stock for Now
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Other News for CHE
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...
Validation Institute Announces Finalists for 2024 Health Value Awards
Chemed Corporation (CHE) Q1 2024 Earnings Call Transcript
Chemed Corp Breaks Below 200-Day Moving Average - Notable for CHE
Chemed (CHE) Receives a Rating Update from a Top Analyst